Cargando…
Matched Whole-Genome Sequencing (WGS) and Whole-Exome Sequencing (WES) of Tumor Tissue with Circulating Tumor DNA (ctDNA) Analysis: Complementary Modalities in Clinical Practice
Tumor heterogeneity, especially intratumoral heterogeneity, is a primary reason for treatment failure. A single biopsy may not reflect the complete genomic architecture of the tumor needed to make therapeutic decisions. Circulating tumor DNA (ctDNA) is believed to overcome these limitations. We anal...
Autores principales: | Imperial, Robin, Nazer, Marjan, Ahmed, Zaheer, Kam, Audrey E., Pluard, Timothy J., Bahaj, Waled, Levy, Mia, Kuzel, Timothy M., Hayden, Dana M., Pappas, Sam G., Subramanian, Janakiraman, Masood, Ashiq |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770276/ https://www.ncbi.nlm.nih.gov/pubmed/31546879 http://dx.doi.org/10.3390/cancers11091399 |
Ejemplares similares
-
Clinical sequencing: is WGS the better WES?
por: Meienberg, Janine, et al.
Publicado: (2016) -
Using the Sankey diagram to visualize article features on the topics of whole-exome sequencing (WES) and whole-genome sequencing (WGS) since 2012: Bibliometric analysis
por: Li, Meng-Ju, et al.
Publicado: (2022) -
Accuracy benchmark of the GeneMind GenoLab M sequencing platform for WGS and WES analysis
por: Li, Chaoyang, et al.
Publicado: (2022) -
PhyloWGS: Reconstructing subclonal composition and evolution from whole-genome sequencing of tumors
por: Deshwar, Amit G, et al.
Publicado: (2015) -
Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer
por: Grunvald, Miles W., et al.
Publicado: (2020)